145 related articles for article (PubMed ID: 24256045)
1. 44-plex cytokine profile of cholesteatoma.
Britze A; Palmfeldt J; Gregersen N; Ovesen T
Acta Otolaryngol; 2014 Jan; 134(1):41-50. PubMed ID: 24256045
[TBL] [Abstract][Full Text] [Related]
2. Comparing machine learning screening approaches using clinical data and cytokine profiles for COVID-19 in resource-limited and resource-abundant settings.
Rashidi HH; Ikram A; Dang LT; Bashir A; Zohra T; Ali A; Tanvir H; Mudassar M; Ravindran R; Akhtar N; Sikandar RI; Umer M; Akhter N; Butt R; Fennell BD; Khan IH
Sci Rep; 2024 Jun; 14(1):14892. PubMed ID: 38937503
[TBL] [Abstract][Full Text] [Related]
3. The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition.
Pietschke K; Holstein J; Meier K; Schäfer I; Müller-Hermelink E; Gonzalez-Menendez I; Quintanilla-Martinez L; Ghoreschi FC; Solimani F; Ghoreschi K
Exp Dermatol; 2021 Feb; 30(2):262-270. PubMed ID: 33113249
[TBL] [Abstract][Full Text] [Related]
4. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
Li Z; Li X; Liu G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
[TBL] [Abstract][Full Text] [Related]
5. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
[TBL] [Abstract][Full Text] [Related]
6. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
[TBL] [Abstract][Full Text] [Related]
8. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Li Y; Xu Z; Zhang L; Quan C; Lin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
[TBL] [Abstract][Full Text] [Related]
9. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
10. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
11. Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.
Malvitte L; Montange T; Vejux A; Baudouin C; Bron AM; Creuzot-Garcher C; Lizard G
Br J Ophthalmol; 2007 Jan; 91(1):29-32. PubMed ID: 16943231
[TBL] [Abstract][Full Text] [Related]
12. Association between human beta defensin expression and cholesteatoma formation.
Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
[TBL] [Abstract][Full Text] [Related]
13. Canal wall down tympanoplasty with canal reconstruction for middle-ear cholesteatoma: post-operative hearing, cholesteatoma recurrence, and status of re-aeration of reconstructed middle-ear cavity.
Ikeda M; Yoshida S; Ikui A; Shigihara S
J Laryngol Otol; 2003 Apr; 117(4):249-55. PubMed ID: 12816211
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis.
Costa-Silva MF; Gomes LI; Martins-Filho OA; Rodrigues-Silva R; Freire Jde M; Quaresma PF; Pascoal-Xavier MA; Mendes TA; Serakides R; Zauli DA; Campi-Azevedo AC; Melo MN; Gontijo CM; Peruhype-Magalhães V; Teixeira-Carvalho A
Mol Immunol; 2014 Feb; 57(2):74-85. PubMed ID: 24084096
[TBL] [Abstract][Full Text] [Related]
15. [Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
Yang X; Li X; Ma M; Zhang L; Zhang Q; Wang J; Wang B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):121-3. PubMed ID: 12768723
[TBL] [Abstract][Full Text] [Related]
16. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
17. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
18. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
19. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
Wang H; Xu Z; Tang A; Su J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
[TBL] [Abstract][Full Text] [Related]
20. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
Xu Y; Wu Z; Tao Z; Hua Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
